Amgen and Wyeth Pharmaceuticals, a division of Wyeth announced that Enbrel (etanercept) (25 mg twice weekly) is the first biologic to be approved by the U.S. Food and Drug Administration (FDA) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results